Showing 111-120 of 1281 results for "".
How to Add Dry Eye Research to Your Clinical Life
https://modernod.com/podcasts/to-the-point/how-to-add-dry-eye-research-to-your-clinical-life/36940/Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, are joined by Sathi Maiti, OD, FAAO, who shares her knowledge and experience working on dry eye clinical research. Dr. Maiti offers great advice on what you need to know before seeking out a clinical trial, how to delegate tasks to youTreating CCH With RF
https://modernod.com/podcasts/to-the-point/treating-cch-with-rf/36938/Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, discuss the benefits of using radio frequency to treat conjunctivochalasis (CCH) with Edward H. Jaccoma, MD, an ophthalmologist who specializes in dry eye and ocular aesthetics. Dr. Jaccoma also offers his insights for patient educatioPreoperative Considerations for the Ocular Surface
https://modernod.com/podcasts/to-the-point/peroperative-considerations-for-the-ocular-surface/36937/Nandini Venkateswaran, MD, joins Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, this month on To the Point to share her insights on preoperative ocular surface considerations. Dr. Venkateswaran offers her approach to optimizing the ocular surface, educating patients on the importanTreating OSD in 2024
https://modernod.com/podcasts/to-the-point/treating-osd-in-2024/36930/Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, kick off 2024 with a conversation about several new and anticipated products for treating ocular surface disease, including cyclosporine ophthalmic solution 0.1% (Vevye, Harrow), perfluorohexyloctane ophthalmic solution (Meibo, BauschSpecialty CLs • Tech Appreciation • Student Perspective
https://modernod.com/podcasts/the-mod-pod/specialty-cls-tech-appreciation-student-perspective/36846/Settle in for an enjoyable audio session with Caitlin Morrison, OD, FAAO, FSLS, third-year optometry student Easy Anyama, and Sulman Hans, OD, MS, FAAO, as you hear them offer reasons to consider fitting specialty contact lenses (1:02), their perspective on the changing landscape of optometry (6:34)Monoclonal Antibodies • Ocular Effects of HRT
https://modernod.com/podcasts/the-mod-pod/monoclonal-antibodies-ocular-effects-of-hrt/36840/This month on The MOD Pod Alissa Coyne, OD, MS, FAAO, FASOS, provides an overview of monoclonal antibodies commonly encountered by optometrists, including side effects to be on the lookout for (1:16). Keeping with the pharmaceutical theme, Cecelia Koetting, OD, FAAO, Dipl ABO, closes the episode witOcular Health-Based Cosmetics
https://modernod.com/podcasts/to-the-point/ocular-health-based-cosmetics/36903/Jackie Garlich, OD, FAAO, and Leslie O’Dell, OD, FAAO, are joined by Amy Gallant Sullivan, executive director and co-creator of the Tear Film & Ocular Surface Society (TFOS) and founder of Eyes Are The Story—a wellness-meets-beauty brand focused on eye health. In this episode, Ms. Gallant SullivThe Importance of Increasing OD-to-OD Referrals
https://modernod.com/mod-issues/2024-apr/the-importance-of-increasing-od-to-od-referrals/38786/And some tips on how to do so.Presbyopia Drops • Glaucoma Diagnostics • Specialty Lenses
https://modernod.com/podcasts/the-mod-pod/presbyopia-drops-glaucoma-diagnostics-specialty-lenses/36822/Rachael A. Wruble, OD, FAAO, leads off the episode with a discussion on how presbyopia-correcting drops will fit into the treatment toolbox (00:45). Daniel Epshtein, OD, FAAO, and co-author Patricia Fulmer, OD, FAAO, follow with a survey of new and next-generation technologies and devices in their pPresbyopia • Dry Eye • Staff Management • OD Profiles
https://modernod.com/podcasts/the-mod-pod/presbyopia-dry-eye-staff-management-od-profiles/36799/Mark Schaeffer, OD, offers guidance for handling presbyopic patients who have never before needed vision correction (0:50). Rebecca Miller, OD, gives advice on how to incorporate autologous serum eye drops into a dry eye protocol (7:58). Get five pearls for improving employee relationships and elimi
